Star Health Seeks Shareholder Approval for Director and Pay Changes

Proposed fixed pay for MD & CEO Mr. Anand Roy stands at ₹7.08 crore per annum, with variable pay at ₹6.37 crore. Independent Directors may receive ₹30 lakh each, subject to shareholder approval.

Key Proposals Filed

Star Health and Allied Insurance has launched a postal ballot to seek shareholder approval for key resolutions. These include continuing Mr. Sumir Chadha as a Nominee Director representing Safecrop Investments India LLP. Shareholders will also vote on reclassifying promoter entities Ebono Private Limited and GS E-commerce Private Limited to the 'Public' category. The ballot also covers new pay packages for senior management, including the MD & CEO, and independent directors. The e-voting period is from May 18 to June 16, 2026, with results due by June 18, 2026.

Why This Matters

These votes are crucial for Star Health's corporate governance. The proposed reclassification of promoters could alter the company's ownership structure and board dynamics. Approved pay raises will directly increase payroll expenses, impacting profitability. Shareholder consent is key for regulatory compliance and maintaining investor trust in management decisions.

Background

Star Health is a leading general insurer in India, mainly offering health insurance. The company completed its IPO in December 2022, raising about ₹7,249 crore. Safecrop Investments India LLP is a major promoter and investor, with Mr. Sumir Chadha as its nominee director. Processes like promoter reclassification are guided by regulations such as the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

What Changes Now

Shareholders will directly influence key governance decisions and executive pay. An approved promoter classification change could alter influence dynamics within the company. The company anticipates higher fixed operating costs if the remuneration increases are approved. Continuation of Safecrop Investments India LLP's board representation is likely if Mr. Chadha's tenure is approved.

Risks to Watch

The results depend on shareholders approving each resolution by the required majority. Any non-compliance with SEBI Listing Regulations during the promoter reclassification process could result in those entities remaining in the 'Promoter Group'. Approved pay raises mean a guaranteed increase in operating expenses. Star Health's prior ₹15 lakh SEBI penalty for IPO disclosure issues underscores the importance of strict regulatory adherence.

Peer Comparison

ICICI Lombard General Insurance: As a major listed peer, its director remuneration and promoter structures offer context, though recent changes aren't directly comparable. New India Assurance Company Ltd: This large insurer also operates within similar regulatory frameworks for governance and executive pay.

Key Compensation Figures

Proposed Compensation Details (FY27 projections):

• Mr. Rajeev Kher: ₹40.00 lakh annually.
• Non-Executive Independent Directors: ₹30.00 lakh each annually.
• MD & CEO Mr. Anand Roy: ₹7.08 crore fixed annual pay, plus ₹6.37 crore variable pay.
• Total for all Non-Executive Independent Directors: Capped at 1% of annual net profits.

What to Track Next

Shareholder voting outcomes for all resolutions.
Announcement of the postal ballot results by June 18, 2026.
Any regulatory feedback or additional approvals needed for the pay hikes.
Market response to the new remuneration plans and any promoter classification changes.
Star Health's future operational performance, considering the impact of higher payroll costs.